z-logo
open-access-imgOpen Access
No Postoperative Adrenal Insufficiency in a Patient with Unilateral Cortisol-Secreting Adenomas Treated with Mifepristone before Surgery
Author(s) -
Rachel M. Saroka,
Michael P. Kane,
Lawrence R. Robinson,
Robert S. Busch
Publication year - 2016
Publication title -
clinical medicine insights endocrinology and diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 15
ISSN - 1179-5514
DOI - 10.4137/cmed.s39997
Subject(s) - medicine , mifepristone , adrenal insufficiency , diabetes mellitus , adrenocorticotropic hormone , glucocorticoid , endocrinology , dexamethasone , dehydroepiandrosterone sulfate , surgery , adrenal gland , gastroenterology , hormone , androgen , pregnancy , genetics , biology
Glucocorticoid replacement is commonly required to treat secondary adrenal insufficiency after surgical resection of unilateral cortisol-secreting adrenocortical adenomas. Here, we describe a patient with unilateral cortisol-secreting adenomas in which the preoperative use of mifepristone therapy was associated with recovery of the hypothalamic-pituitary-adrenal (HPA) axis, eliminating the need for postoperative glucocorticoid replacement.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom